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remained signiﬁcant even after further adjustment for the indica-
tors of the metabolic syndrome, including waist circumference,
systolic blood pressure, diastolic blood pressure, triglyceride,
HDL cholesterol and fasting plasma glucose, the adjusted hazard
ratio (95% CI) was 2.21 (1.42–3.44). These results indicated that
subclinical hypothyroidism is an independent factor that predicts
the development of NAFLD.
A limitation of this study is that ultrasound examination is not
sensitive enough to detect mild steatosis. However, ultrasonogra-
phy is the most commonly used in epidemiological surveys of
NAFLD. Ultrasonography has the advantage of being non-inva-
sive, safe, widely available, and sensitivity for detecting hepatic
steatosis is acceptable. Another limitation is that the causal rela-
tionship between subclinical hypothyroidism and development
of NAFLD could not been drawn by this study. Further evidence
is needed to clarify this issue.
Taken together, our prospective case-control study provided
evidence that subclinical hypothyroidism is a signiﬁcant factor
associated with NAFLD development. This ﬁnding may have
important clinical implications for disease therapy and
prevention.
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Letters to the Editor
1154Regulatory T cell defects in adult autoimmune hepatitisTo the Editor:
Peiseler et al. report that FOXP3pos regulatory T cells (Treg) in
adult patients with autoimmune hepatitis (AIH) are ‘‘fully func-
tional and not reduced in frequency’’ [1].
We wish to make a few comments.
Quoting previous literature on Tregs in AIH [2,3], the authors
state that most information has been obtained in paediatric cases.
We have published data on 47 adult patients with AIH type 1
conﬁrming the ﬁndings obtained in the paediatric setting and
reported that the frequency of CD4posCD25highFOXP3pos cells is
markedly reduced in AIH compared to healthy subjects, that this
decrease is more marked when the disease is more active and
that the numerical impairment is mirrored by the defective abil-
ity of Treg cells to control proliferation of CD4posCD25neg target
cells [4]. We have also shown that the decrease in Tregs is paral-
leled by a numerical impairment in natural killer T (NKT) cells [4],
a subset of cells with regulatory properties, suggesting that, con-Journal of Hepatology 20trary to what proposed by Peiseler et al., a broad immune-regula-
tory T cell defect is probably present in AIH.
The contrasting peripheral blood results between Peiseler
et al. and our study probably derive from methodological
differences. It is, however, difﬁcult to compare our methods with
those used in their paper, as they do not describe in detail their
methodology. The purity of their CD4posCD25high Treg is only
80–90%, and no data are provided to assess the efﬁciency of the
puriﬁcation protocol they have used (they refer to preliminary
results, but do not show them) or whether their puriﬁed cells
are CD127low. Moreover, in contrast to previous reports [2,3],
including ours [4], Peiseler et al. use a Treg/T-effector ratio of 1/
1 when assessing the suppressor function, while Tregs normally
represent some 4% of the total CD4+ lymphocyte population in
the human blood [5].
Concerning the immunohistochemistry data, Peiseler et al. say
that their results differ from ours [4], as, in contrast to us, they12 vol. 57 j 1152–1159
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ﬁnd increased numbers of FOXP3pos cells within the inﬂamma-
tory inﬁltrate of patients with AIH. In our study, FOXP3pos cells
were detected in most liver biopsies from AIH patients, but they
represented a small component of the portal tract inﬂammatory
inﬁltrate. No comparison was made with normal or pathological
control livers. As FOXP3pos cells are reportedly absent or scarce in
the normal liver, when tested by immunohistochemistry [6,7], it
can be argued that we did ﬁnd increased numbers of tissue
FOXP3pos cells in AIH. In support of their ﬁndings, Peiseler et al.
refer to Buckner’s review [5], which quotes increased numbers
of tissue FOXP3pos cells in human autoimmune disease, such as
in the skin in psoriasis and in the gut in inﬂammatory bowel
disease. Interestingly, in the same review [5] Treg function is
documented to be decreased in most human autoimmune
diseases, including type 1 diabetes, multiple sclerosis, systemic
lupus erythematosus, rheumatoid arthritis and psoriasis, in
agreement with what reported by us [4] and others [2,3] in AIH.
Of note, a numerical defect of peripheral Tregs has been
reported in primary biliary cirrhosis (PBC), another autoimmune
liver disease [6]. In the same paper, the frequency of FOXP3pos
cells within the CD3pos liver inﬁltrating T lymphocytes was
approximately 12% in PBC, 18% in AIH, and 28% in chronic hepa-
titis C [6], though a more recent paper by Oo et al. has reported a
frequency of about 12% in both AIH and PBC [7]. As acknowledged
by Peiseler et al. [1] and Bukner [5], the use of FOXP3 as sole mar-
ker of Tregs in tissues is inadequate, FOXP3 being also expressed
by effector T cells following activation [5]: more accurate infor-
mation will be obtained when better markers for immunohisto-
chemical detection of Tregs become available.
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To the Editor:
We read with interest the comment by Ferri et al. to our paper
on Tregs in autoimmune hepatitis (AIH) [1], in which they
emphasise several discrepancies between their recently pub-
lished ﬁndings [2] and ours. Ferri et al. explain these discrepan-
cies by methodological differences; however, ﬁnd it difﬁcult to
compare the methodologies. We are grateful for the opportunity
to clarify our methodology in comparison to that used by Ferri
et al.
(1) Ferri et al. report that the frequency of CD4+CD25high-
FOXP3+ cells ‘‘is markedly reduced in AIH compared to
healthy subjects’’, whereas we ﬁnd that the frequency of
CD4+CD25(high)CD127(low)FOXP3+ in blood of AIH
patients was not reduced compared to healthy subjects.
To determine the Treg frequency in peripheral blood, Ferri
et al. ﬁrst puriﬁed CD4+CD25+ lymphocytes from periphe-
ral blood by a two-step magnetic puriﬁcation procedure,
i.e. depletion of non-CD4 cells followed by enrichment of
CD25+ cells. Only then, the percentage of FOXP3+ cells in
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the isolated subgroup of blood cells was determined. In
contrast, we did not isolate a subfraction of cells from
peripheral blood, but instead performed a direct ex vivo
analysis of unfractionated peripheral blood cells by stain-
ing for CD4, CD25, FOXP, and CD127. The gating strategy
for this analysis is actually shown in Fig. 1A of our paper.
We see at least two critical advantages of our approach:
ﬁrst, by direct ex vivo analysis, we avoid the potential
selection bias that is inevitable when performing a sub-
fraction analysis after an enrichment procedure; second,
by including CD127 as an additional marker, we greatly
increase the ﬁdelity of Treg identiﬁcation. Moreover, we
conﬁrmed the ﬁndings obtained by this method with
another method, i.e. analysis of the FOXP3 TSDR DNA
methylation status.
(2) Ferri et al. ﬁnd a ‘‘defective ability of Treg cells to control the
proliferation of CD4+CD25- target cells’’; while we do not
ﬁnd a reduced suppressor function of Treg from AIH
patients. To determine Treg suppressor function, Ferri et
al. used the 3H-thymidine assay; we, in contrast, used
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